Texas Capital Bancshares Depositary Shares 5 75 Non Cum Pref Shs Series B (TCBIO) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	328.35M	316.48M	307.98M	317.50M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	172.16M	164.94M	195.88M	183.68M
Operating expense	185.38M	181.92M	208.69M	200.91M
Total operating expenses	185.38M	181.92M	208.69M	200.91M
Operating income	142.98M	134.56M	99.29M	116.59M
Other non operating income	-5.20M	-4.48M	-4.88M	-4.59M
EBT including unusual items	137.78M	132.28M	94.42M	112.00M
EBT excluding unusual items	137.78M	130.08M	94.42M	112.00M
Income tax expense	32.57M	31.63M	20.63M	27.05M
Effective tax rate	23.64%	23.91%	21.85%	24.15%
Other operating expenses	13.21M	16.98M	12.82M	17.23M
Net income	105.21M	100.66M	73.79M	84.95M
Net profit margin	32.04%	31.81%	23.96%	26.76%
Earnings per share	2.18	2.08	1.58	1.88
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance